MotionHall
MotionHall is a Silicon Valley technology company specializing in strategic intelligence and advisory for the global biopharma industry. Founded in 2016, it offers a proprietary platform that combines advanced AI-driven data science with deep industry expertise to provide detailed company profiles, competitive landscapes, and market evaluations focused on biotechnology, branded and generic pharmaceuticals, and life sciences. The company supports senior biopharma executives and their teams worldwide, enabling them to optimize deal planning, venture investment, strategic partnerships, and M&A activities. MotionHall's business model includes platform access and senior strategy consulting services, leveraging a small, high-powered team of industry veterans and frontier engineers. The company has developed over $6 billion in company value for its members and maintains a global reach with strong coverage in North America, Europe, Asia Pacific, Latin America, Israel, and India.
MotionHall
MotionHall is a Silicon Valley technology company specializing in strategic intelligence and advisory for the global biopharma industry. Founded in 2016, it offers a proprietary platform that combines advanced AI-driven data science with deep industry expertise to provide detailed company profiles, competitive landscapes, and market evaluations focused on biotechnology, branded and generic pharmaceuticals, and life sciences. The company supports senior biopharma executives and their teams worldwide, enabling them to optimize deal planning, venture investment, strategic partnerships, and M&A activities. MotionHall's business model includes platform access and senior strategy consulting services, leveraging a small, high-powered team of industry veterans and frontier engineers. The company has developed over $6 billion in company value for its members and maintains a global reach with strong coverage in North America, Europe, Asia Pacific, Latin America, Israel, and India.
TL;DR
Headquarters: San Francisco, CA
Founded: 2016
Core offering: AI-driven dealmaking platform and strategic advisory for biopharma
Exit: Acquired by Clarivate (announced March 21, 2024)
Company Overview
Problem Domain
Life-sciences dealmaking and business development for biotechnology, branded and generic pharmaceuticals, and life sciences companies.
Founded
2016
Industry
Life sciences / Biopharma
Funding Track Record
Public profiles list investors including Village Global, First Star Ventures, Outlier Ventures and Right Side Capital Management; company was acquired by Clarivate (announced March 21, 2024).
Investor Signal
“Venture-backed (investors include Village Global, First Star Ventures, Outlier Ventures, Right Side Capital Management)”